T. Monney

发表

Differential Effects on Survival, Humoral Immune Responses and Brain Lesions in Inbred BALB/C, CBA/CA, and C57BL/6 Mice Experimentally Infected with Neospora caninum Tachyzoites

A. Hemphill, E. Boerhout, T. Mols-Vorstermans, 2013, ISRN parasitology.

Vaccination of mice with chitosan nanogel‐associated recombinant NcPDI against challenge infection with Neospora caninum tachyzoites

P. Kaeuper, K. McCullough, C. Kropf, 2011, Parasite immunology.

Vaccines against neosporosis: what can we learn from the past studies?

A. Hemphill, T. Monney, 2014, Experimental parasitology.

Single-step Protein A and Protein G avidity purification methods to support bispecific antibody discovery and development

G. Gudi, Daniel Ayoub, P. Wassmann, 2019, mAbs.

Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodies

P. Wassmann, T. Monney, E. Svensson, 2017, The Journal of Biological Chemistry.

Use of a Th1 Stimulator Adjuvant for Vaccination against Neospora caninum Infection in the Pregnant Mouse Model

S. Leib, A. Hemphill, D. Grandgirard, 2013, Pathogens.

Proteins mediating the Neospora caninum-host cell interaction as targets for vaccination.

Joachim Mueller, A. Hemphill, T. Monney, 2013, Frontiers in bioscience.

Di-cationic arylimidamides act against Neospora caninum tachyzoites by interference in membrane structure and nucleolar integrity and are active against challenge infection in mice.

D. Boykin, Joachim Müller, A. Hemphill, 2012, International journal for parasitology. Drugs and drug resistance.

Vaccination with the recombinant chimeric antigen recNcMIC3-1-R induces a non-protective Th2-type immune response in the pregnant mouse model for N. caninum infection.

S. Leib, A. Hemphill, D. Grandgirard, 2012, Vaccine.

RecNcMIC3-1-R is a microneme- and rhoptry-based chimeric antigen that protects against acute neosporosis and limits cerebral parasite load in the mouse model for Neospora caninum infection.

S. Leib, A. Hemphill, D. Rütti, 2011, Vaccine.

Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites.

Joachim Müller, S. Leib, A. Hemphill, 2009, International journal for parasitology.

Vaccines against a Major Cause of Abortion in Cattle, Neospora caninum Infection

A. Hemphill, T. Monney, K. Debache, 2011, Animals : an open access journal from MDPI.

ISB 1342: A first-in-class CD38 T cell engager for the treatment of relapsed refractory multiple myeloma.

M. Perro, M. Doucey, Adam Drake, 2021, Journal of Clinical Oncology.

ISB 1442, a First-in-Class CD38 and CD47 Bispecific Antibody Innate Cell Modulator for the Treatment of Relapsed Refractory Multiple Myeloma

G. Gudi, M. Panagopoulou, C. Grandclément, 2021, Blood.

Pre-clinical characterization of ISB 1342, a CD38xCD3 T-cell engager for relapsed/refractory multiple myeloma.

Ankit Srivastava, G. Gudi, G. Borthakur, 2023, Blood.

Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma

T. Monney, E. Dheilly, A. Rubod, 2024, Nature communications.